PMID: 15244206Jul 13, 2004Paper

Lamivudine treatment in patients with hepatitis B virus induced liver cirrhosis

Hepato-gastroenterology
Karaca CetinOkten Atilla

Abstract

First studies have suggested a beneficial effect of lamivudine in patients with cirrhosis caused by replicating hepatitis B virus. Whether long-term lamivudine therapy is effective in HBV-related liver cirrhosis patients was prospectively evaluated. Thirty-one patients with hepatitis B virus-related compensated/decompensated cirrhosis, all with quantitative DNA +ve by hybridization (10 HBeAg +ve, 21 anti-HBe +ve), received lamivudine 100 mg/day for average 16.3 (4-34) months. At the end of therapy HBeAg seroconversion was observed in one patient. HBV DNA lost in all patients except two. Albumin levels increased (p<0.05). ALT levels and Child-Pugh-Turcotte scores decreased (p<0.05). Any complication related with liver cirrhosis was not observed during treatment period despite spontaneous ascitic infection in one and hepatic coma in two were occurred before therapy. Only one patient had clinical breakthrough presented by increase in ALT levels and reappearing of HBV DNA during therapy. In patients with cirrhosis caused by replicating hepatitis B virus, prolonged therapy with lamivudine is well tolerated and resulted in improved serum biochemical values and loss of HBV DNA. Clinical improvements may also occur.

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.